ensituximab April 12, 2017 ensituximab Trade Name Orphan Indication Pancreatic cancer USA Market Approval USA USA Designation Date 2010-10-21 00:00:00 Sponsor Neogenix Oncology, Inc.;9700 Great Seneca Highway;Rockville, Maryland, 20850
